Patent US5879383A successfully refreshed from Google Patents.
US5879383A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Blood contact surfaces using endothelium on a subendothelial matrix
Assignee: W.L. Gore and Associates Inc
•
Filing: 1997-06-30
•
Granted: 1999-03-09
•
Expires: 2017-06-30
Abstract
Abstract This invention relates to improved blood contact devices such as vascular prostheses rendered antithrombotic through the use of recipient endothelial cells grown on an appropriate subendothelial matrix. The subendothelial matrix layer, which serves as the substratum for growing endothelial cells, may be obtained from either natural donor vessels or from in vitro tissue culture sources. This subendothelial matrix is used in situ on the donor vessel, or is grown or applied to a synthetic component, preferably porous expanded polytetrafluoroethylene. Once this subendothelial matrix is prepared, recipient endothelial cells are seeded onto this matrix substratum, which then serves as the immediate blood contact surface. The endothelial cells may be applied as an intra-operative procedure, or grown on the subendothelial matrix substratum in vitro until the cells establish a confluent monolayer. A key aspect of this invention is that living, recipient endothelial cells are grown on the appropriate subendothelial matrix substratum, thereby providing a substantially nonthrombotic blood contact surface. Furthermore, the likelihood of recipient immunological response is minimized. This invention results in vascular prostheses that are particularly useful for arterial bypass requiring a diameter of 6 mm or less.
Inventors
- 👤 William Carl Bruchman
- 👤 Paul Christopher Begovac
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:18
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/507; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61L27/14; A61L27/16
Claims Analysis
Total Claims: 45
Claim 1
Independent Claim
84 words
A blood contact material comprising: a synthetic base material comprising porous polytetrafluoroethylene; a substratum attached to the synthetic base material, said substratum comprising a preserved subendothelial matrix layer that supports attachment and growth of applied cardiovascular endothelial cells thereon; a layer of applied cardiovascular endothelial cells attached to the preserved subendothelial matrix layer; wherein the cardiovascular endothelial serve as a direct blood contact surface; and wherein, in the absence of cells attached to the substratum, the substratum servers as a direct blood contact surface.
Claim 2
Dependent Claim
84 words
A blood contact material comprising: a synthetic base material comprising porous polytetrafluoroethylene; a substratum attached to the synthetic base material, said substratum comprising a preserved subendothelial matrix layer that supports attachment and growth of applied cardiovascular endothelial cells thereon; a layer of applied cardiovascular endothelial cells attached to the preserved subendothelial matrix layer; wherein the cardiovascular endothelial serve as a direct blood contact surface; and wherein, in the absence of cells attached to the substratum, the substratum servers as a direct blood contact surface.
Claim 3
Dependent Claim
16 words
The blood contact material of claim 1 wherein the synthetic base material comprises a tubular structure.
Claim 4
Dependent Claim
21 words
The blood contact material of claim 1 wherein the synthetic base material comprises at least a portion of a heart valve.
Claim 5
Dependent Claim
16 words
The blood contact material of claim 1 wherein the synthetic base material comprises a flexible sheet.
Claim 6
Dependent Claim
35 words
The blood contact material of claim 1 wherein the synthetic base material further comprises polymeric materials selected from the group consisting of polytetrafluoroethylene, polyethylene tetraphthalate, polypropylene, and fluorinated, ethylene propylene, either alone, or in combination.
Claim 7
Dependent Claim
35 words
The blood contact surface of claim 1, wherein the substratum contains at least one protein in a group consisting of chondroitin sulfate proteoglycans, fibronectin, collagen Type I, collagen Type III, collagen Type IV, and elastin.
Claim 8
Dependent Claim
77 words
The blood contact surface of claim 1 wherein the surface is formed through the following process: providing a donor blood vessel comprising an endothelial cell layer attached to a subendothelial matrix layer attached to a smooth muscle cell layer; stripping the endothelial cell layer from the subendothelial matrix layer of the donor blood vessel to produce a subendothelial matrix substratum substantially free of endothelial cells; preserving the subendothelial matrix; and applying cardiovascular endothelial cells to the substratum.
Claim 9
Dependent Claim
23 words
The process of claim 7 which further comprises: stripping the endothelial cell layer from the subendothelial layer by treating with a stripping solution.
Claim 10
Dependent Claim
26 words
The process of claim 8 wherein the stripping solution is an aqueous solution of ammonium hydroxide at a concentration ranging from about 0.01M to about 0.5M.
Claim 11
Dependent Claim
19 words
The process of claim 7 that further comprises: stripping the endothelial cell layer by freeze-thaw treating the endothelial layer.
Claim 12
Dependent Claim
20 words
The process of claim 7 which further comprises: stripping the endothelial cell layer by air dry treating the endothelial layer.
Claim 13
Dependent Claim
39 words
The process of claim 7, which further comprises: removing the subendothelial matrix layer from the donor blood vessel and applying the subendothelial matrix layer to a synthetic component, the subendothelial matrix layer serving as a direct blood contact surface.
Claim 14
Dependent Claim
40 words
The process of claim 7 which further comprises: treating the subendothelial matrix layer and any associated vascular tissue to reduce calcification by saturating the subendothelial matrix layer and any associated vascular tissue with a solution that predominantly extracts lipid components.
Claim 15
Dependent Claim
19 words
The process of claim 13 wherein the solution used to reduce calcification is a solution of chloroform and methanol.
Claim 16
Dependent Claim
23 words
The process of claim 13 which further comprises: treating the subendothelial matrix layer with a fixative solution to preserve the subendothelial matrix layer.
Claim 17
Dependent Claim
14 words
The process of claim 15 wherein the fixative solution is a solution of ethanol.
Claim 18
Dependent Claim
14 words
The process of claim 15 wherein the fixative solution is a solution of glutaraldehyde.
Claim 19
Independent Claim
109 words
A method of producing a blood contact surface which comprises: providing a donor blood vessel comprising a layer of endothelial cells attached to a subendothelial matrix layer attached to a layer of smooth muscle cells; treating the blood vessel so as to remove the endothelial cells while leaving the subendothelial matrix layer in situ to form a substratum; employing the substratum as a direct blood contact surface in an appliance, in the absence of cells attached to the substratum; growing vascular endothelial cells on the substratum to form a vascular endothelial cell layer; and employing the vascular endothelial cell layer as a direct blood contact surface in an appliance.
Claim 20
Independent Claim
109 words
A method of producing a blood contact surface which comprises: providing a donor blood vessel comprising a layer of endothelial cells attached to a subendothelial matrix layer attached to a layer of smooth muscle cells; treating the blood vessel so as to remove the endothelial cells while leaving the subendothelial matrix layer in situ to form a substratum; employing the substratum as a direct blood contact surface in an appliance, in the absence of cells attached to the substratum; growing vascular endothelial cells on the substratum to form a vascular endothelial cell layer; and employing the vascular endothelial cell layer as a direct blood contact surface in an appliance.
Claim 21
Dependent Claim
25 words
The method of claim 18 which further comprises: employing the substratum as an appliance comprising an artificial vascular prosthesis obtained from a donor blood vessel.
Claim 22
Dependent Claim
45 words
The method of claim 19 which further comprises: surrounding the artificial vascular prosthesis along its length with a sheath comprising a material which permits the passage of macromolecules through the sheath, while resisting ingrowth of cells from tissue surrounding the artificial vascular prosthesis when implanted.
Claim 23
Dependent Claim
39 words
The method of claim 18, which further comprises: extracting the subendothelial matrix layer from a donor blood vessel and applying the subendothelial matrix layer to a synthetic component, the subendothelial matrix layer serving as a direct blood contact surface.
Claim 24
Dependent Claim
13 words
The method of claim 21, which further comprises: preserving the subendothelial matrix layer.
Claim 25
Dependent Claim
30 words
The method of claim 18 which further comprises: treating the subendothelial matrix layer and any associated vascular tissue layers to reduce calcification with a solution that predominantly extracts lipid components.
Claim 26
Dependent Claim
19 words
The method of claim 23 wherein the solution used to reduce calcification is a solution of chloroform and methanol.
Claim 27
Dependent Claim
23 words
The method of claim 22 which further comprises: treating the subendothelial matrix layer with a fixative solution to preserve the subendothelial matrix layer.
Claim 28
Dependent Claim
14 words
The method of claim 25 wherein the fixative solution is a solution of ethanol.
Claim 29
Dependent Claim
14 words
The method of claim 25 wherein the fixative solution is a solution of glutaraldehyde.
Claim 30
Independent Claim
142 words
A method of producing a blood contact surface which comprises: co-culturing endothelial cells and smooth muscle cells in vitro to establish an endothelial cell layer overlying a smooth muscle cell layer; incubating the co-culture until a subendothelial matrix layer is formed between the donor endothelial cell layer and a smooth muscle cell layer by the interaction of the smooth muscle cells and the donor endothelial cells; treating the co-cultured endothelial cell layer and the smooth muscle cell layer so as to remove the donor endothelial cells thereby forming a subendothelial matrix substratum; employing the substratum as a direct blood contact surface in an appliance, in the absence of cells attached to the substratum; growing vascular endothelial cells on the substratum to form an endothelial cell layer; and employing the vascular endothelial cell layer as a direct blood contact surface in an appliance.
Claim 31
Independent Claim
142 words
A method of producing a blood contact surface which comprises: co-culturing endothelial cells and smooth muscle cells in vitro to establish an endothelial cell layer overlying a smooth muscle cell layer; incubating the co-culture until a subendothelial matrix layer is formed between the donor endothelial cell layer and a smooth muscle cell layer by the interaction of the smooth muscle cells and the donor endothelial cells; treating the co-cultured endothelial cell layer and the smooth muscle cell layer so as to remove the donor endothelial cells thereby forming a subendothelial matrix substratum; employing the substratum as a direct blood contact surface in an appliance, in the absence of cells attached to the substratum; growing vascular endothelial cells on the substratum to form an endothelial cell layer; and employing the vascular endothelial cell layer as a direct blood contact surface in an appliance.
Claim 32
Dependent Claim
43 words
The method of claim 28 which further comprises: removing the subendothelial matrix layer from the smooth muscle cell layer and applying the subendothelial matrix substratum to a surface of an artificial vascular prosthesis upon which the blood contact surface is to be located.
Claim 33
Dependent Claim
51 words
The method of claim 28 which further comprises: co-culturing the endothelial cells and the smooth muscle cells in vitro on a surface of an artificial vascular prosthesis upon which the blood contact surface is to be located, in order to establish the endothelial cell layer overlying the smooth muscle cell layer.
Claim 34
Dependent Claim
41 words
The blood contact surface of claim 30 wherein the artificial vascular prosthesis is a tubular vascular prosthesis having an interior surface and an exterior surface wherein the in vitro co-culture is conducted on the interior surface of the tubular vascular prosthesis.
Claim 35
Dependent Claim
16 words
The method of claim 28 that further comprises: employing endothelial cells that are vascular endothelial cells.
Claim 36
Dependent Claim
18 words
The method of claim 28 which further comprises: employing smooth muscle cells that are vascular smooth muscle cells.
Claim 37
Dependent Claim
23 words
The method of claim 28 which further comprises: treating the subendothelial matrix layer with a fixative solution to preserve the subendothelial matrix layer.
Claim 38
Dependent Claim
14 words
The method of claim 34 wherein the fixative solution is a solution of ethanol.
Claim 39
Dependent Claim
14 words
The method of claim 34 wherein the fixative solution is a solution of glutaraldehyde.
Claim 40
Dependent Claim
74 words
An artificial vascular prosthesis which comprises: a de-endothelialized subendothelial matrix layer preserved with a fixative, the substratum serving as foundation upon which vascular endothelial cells attach and grow to form a vascular endothelial cell layer; wherein the vascular endothelial cell layer serves as a direct blood contact surface; and wherein, in the absence of cells attached to the preserved subendothelial matrix layer, the preserved subendothelial matrix layer serves as a direct blood contact surface.
Claim 41
Dependent Claim
74 words
An artificial vascular prosthesis which comprises: a de-endothelialized subendothelial matrix layer preserved with a fixative, the substratum serving as foundation upon which vascular endothelial cells attach and grow to form a vascular endothelial cell layer; wherein the vascular endothelial cell layer serves as a direct blood contact surface; and wherein, in the absence of cells attached to the preserved subendothelial matrix layer, the preserved subendothelial matrix layer serves as a direct blood contact surface.
Claim 42
Dependent Claim
28 words
The artificial vascular prosthesis of claim 37 wherein, the subendothelial matrix layer is obtained from a donor blood vessel and preserved in situ in the donor blood vessel.
Claim 43
Dependent Claim
44 words
The artificial vascular prosthesis of claim 37 wherein, the subendothelial matrix layer is produced by in vitro co-culture of endothelial cells and smooth muscle cells and applied to a surface of an artificial vascular prosthesis which will serve as a direct blood contact surface.
Claim 44
Dependent Claim
43 words
The artificial vascular prosthesis of claim 37 wherein, the subendothelial matrix layer is produced by in vitro co-culture of endothelial cells and smooth muscle cells conducted on a surface of an artificial vascular prosthesis which will serve as a direct blood contact surface.
Claim 45
Dependent Claim
40 words
The artificial vascular prosthesis of claim 37, wherein, prior to preservation of the de-endothelialized subendothelial matrix layer, the de-endothelialized subendothelial matrix layer and any vascular tissue layers externally attached to the de-endothelialized subendothelial matrix layer are treated to reduce calcification.
References Cited (Backward Citations)
US3562820A
Cited
US3953566A
Cited
US4187390A
Cited
US3988782A
Cited
US3966401A
Cited
US4050893A
Cited
US4098571A
Cited
US4539716A
Cited
US4323358A
Cited
US4546500A
Cited
US4960423A
Cited
US4553974A
Cited
US4804382A
Cited
US4883755A
Cited
US5037378A
Cited
EP0531547A1
Cited
US5429938A
Cited
US5549674A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-03-08 | 2002-09-07 | 2003-03-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-03-08 | 2006-09-07 | 2007-03-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-03-08 | 2010-09-07 | 2011-03-09 | $7700.00 | Window Closed / Lapsed |